Consideration of comorbidity in cancer treatment decision-making in multidisciplinary team meetings
the ONA take:
Comorbidity is very common among patients with cancer. Yet little is known about how comorbidity is factored into treatment decision making for these patients.
Treatment decisions are increasingly made within the context of multidisciplinary team meetings (MDTs). A systematic literature review was conducted to determine if and how comorbidity influences MDT decision-making.
The review included 21 original studies. Findings demonstrate that a lack of information on comorbidity impedes the ability to make treatment recommendations as well as to implement those recommendations.
Adjustments to recommended treatment due to comorbidity tends to result in a more conservative approach, despite evidence that treatments are tolerated and effective.
The review concludes that further research is needed to assist MDTs in appropriately addressing comorbidity in their treatment decisions, which can improve outcomes for cancer patients with comorbidities.
Little is known about how comorbidity is factored into treatment decision making for these patients.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|